- Coloplast A/S - Selskabsmeddelelse nr. 02/2023 - Regnskabsmeddelelse, 1. halvår 2022/23
- Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23
- Studie viser signifikant forbedring af blæretømning med Coloplasts Luja™ sammenlignet med konkurrentkateter
- Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter
- Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
- Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier
- Coloplast A/S - Allokering af aktieoptioner
- Coloplast A/S - Allocation of Share Options
- Coloplast lancerer nyt kateter til mænd udviklet til at mindske risikoen for urinvejsinfektioner
- Coloplast launches male catheter designed to reduce the risk of urinary tract infections
More ▼
Key statistics
As of last trade Coloplast A/S (CBHD:DUS) traded at 117.70, -12.03% below its 52-week high of 133.80, set on May 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 117.70 |
---|---|
High | 117.70 |
Low | 117.70 |
Bid | 117.05 |
Offer | 118.00 |
Previous close | 116.45 |
Average volume | 257.18 |
---|---|
Shares outstanding | 198.00m |
Free float | 108.81m |
P/E (TTM) | 38.75 |
Market cap | 173.21bn DKK |
EPS (TTM) | 22.58 DKK |
Annual div (ADY) | 2.69 EUR |
---|---|
Annual div yield (ADY) | 2.31% |
Div ex-date | May 15 2023 |
Div pay-date | May 17 2023 |
Data delayed at least 15 minutes, as of Jun 02 2023 07:10 BST.
More ▼